Related Experiment Video
Updated: Jun 18, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Clinical Management of Familial Hypercholesterolemia in Children
Kurt Widhalm1, Karin Fallmann1
1Austrian Academic Institute for Clinical Nutrition, Medical University of Vienna, Austria.
Insights
Familial Hypercholesterolemia (FH) affects 1 in 250 people, but only 10% are diagnosed. Early screening and treatment in children with FH are crucial for preventing cardiovascular diseases.
Area of Science:
- Metabolic Disorders
- Genetics
- Pediatric Cardiology
Background:
- Familial Hypercholesterolemia (FH) is a common genetic disorder affecting lipid metabolism.
- Despite being well-characterized, FH has a low diagnosis rate (approx. 10%) globally.
- Early cardiovascular disease risk is high in untreated FH patients.
Purpose of the Study:
- To describe the clinical and pathophysiological characteristics of FH in children.
- To outline nutritional and medical therapies for pediatric FH.
- To emphasize the importance of early diagnosis and intervention for FH.
Main Methods:
- Literature review of clinical studies on FH in children and adolescents.
- Analysis of pathophysiological mechanisms underlying FH.
- Summary of current therapeutic strategies, including diet and medication.
Main Results:
- FH prevalence is estimated at 1:250, with significant underdiagnosis.
- Children and adolescents with FH exhibit elevated Total cholesterol and LDL-c.
- Early treatment is recommended to mitigate cardiovascular risks.
Conclusions:
- Screening for FH in children aged 6-10 years is cost-effective.
- Timely intervention in pediatric FH can prevent premature cardiovascular events.
- Increased awareness and improved diagnostic rates are essential for managing FH.
Abstract:
Familial Hypercholesterolemia (FH) is one of the best-characterized inborn errors of metabolism, with an estimated prevalence of 1:250 in the general population. Only approximately 10% of the affected subjects are diagnosed and, therefore, under medical care, including drug therapy or, in severe cases, apheresis. Screening at the age of 6-10 years would be useful and cost-effective. There is enough evidence that children and adolescents with FH should be treated in order to reduce elevated Total cholesterol and LDL-c levels and, therefore, avoid the risk of early cardiovascular diseases. As FH was described more than 130 years ago, it is surprising that the knowledge of that very important metabolic disorder is insufficient. The present report describes clinical and pathophysiological characteristics and nutritional and medical therapies in children with familial hypercholesterolemia.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Chronic Pancreatitis II: Collaborative Care
Assessment:
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cystic Fibrosis: Management
Sinus disease and chronic...

